Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Rosel

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
Biological Psychiatry|October 1, 1995
Changes in platelet 3-H-imipramine binding: influences of protein concentration of varying proportions of cytosol or intact platelets and displacing agents usedP Rosel-Soria, J Vallejo, M Oros, et al.
Medicina Clinica|June 8, 1991
[Clinical and methodological considerations in the quantification of estrogen and progesterone receptors using monoclonal antibodies in breast cancer]M A Navarro, J Huguet, J Valero, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|October 21, 1999
Platelet serotonergic binding sites in alcohol-dependent patientsB Arranz, P Rosel, S Sarró, et al.
Journal of Affective Disorders|June 1, 1997
Platelet [3H]imipramine and [3H]paroxetine binding in depressed patientsP Rosel, J M Menchón, J Vallejo, et al.
Psychiatry Research|November 9, 2000
Altered 5-HT(2A) binding sites and second messenger inositol trisphosphate (IP(3)) levels in hippocampus but not in frontal cortex from depressed suicide victimsP Rosel, B Arranz, L San, et al.
Journal of Affective Disorders|September 3, 2002
Loss of the circadian variation of platelet [3H]imipramine binding in delusional compared with non-delusional endogenously depressed patientsJ Vallejo, P Rosel, B Arranz, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|January 1, 1997
High affinity [3H]imipramine and [3H]paroxetine binding sites in suicide brainsP Rosel, B Arranz, J Vallejo, et al.
Journal of Affective Disorders|June 5, 1999
Altered [3H]imipramine and 5-HT2 but not [3H]paroxetine binding sites in platelets from depressed patientsP Rosel, B Arranz, J Vallejo, et al.
Revista Clinica Espanola|September 30, 1980
[Protocol of simplified diagnostic evaluation of the hypertensive patient. Comparative results]A Caralps, A Martínez-Amenós, H Rama, et al.
Psychiatry Research|October 1, 1998
Variations in [3H]imipramine and 5-HT2A but not [3H]paroxetine binding sites in suicide brainsP Rosel, B Arranz, J Vallejo, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Biological Psychiatry|October 1, 1995
Changes in platelet 3-H-imipramine binding: influences of protein concentration of varying proportions of cytosol or intact platelets and displacing agents usedP Rosel-Soria, J Vallejo, M Oros, et al.
Medicina Clinica|June 8, 1991
[Clinical and methodological considerations in the quantification of estrogen and progesterone receptors using monoclonal antibodies in breast cancer]M A Navarro, J Huguet, J Valero, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|October 21, 1999
Platelet serotonergic binding sites in alcohol-dependent patientsB Arranz, P Rosel, S Sarró, et al.
Journal of Affective Disorders|June 1, 1997
Platelet [3H]imipramine and [3H]paroxetine binding in depressed patientsP Rosel, J M Menchón, J Vallejo, et al.
Psychiatry Research|November 9, 2000
Altered 5-HT(2A) binding sites and second messenger inositol trisphosphate (IP(3)) levels in hippocampus but not in frontal cortex from depressed suicide victimsP Rosel, B Arranz, L San, et al.
Journal of Affective Disorders|September 3, 2002
Loss of the circadian variation of platelet [3H]imipramine binding in delusional compared with non-delusional endogenously depressed patientsJ Vallejo, P Rosel, B Arranz, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|January 1, 1997
High affinity [3H]imipramine and [3H]paroxetine binding sites in suicide brainsP Rosel, B Arranz, J Vallejo, et al.
Journal of Affective Disorders|June 5, 1999
Altered [3H]imipramine and 5-HT2 but not [3H]paroxetine binding sites in platelets from depressed patientsP Rosel, B Arranz, J Vallejo, et al.
Revista Clinica Espanola|September 30, 1980
[Protocol of simplified diagnostic evaluation of the hypertensive patient. Comparative results]A Caralps, A Martínez-Amenós, H Rama, et al.
Psychiatry Research|October 1, 1998
Variations in [3H]imipramine and 5-HT2A but not [3H]paroxetine binding sites in suicide brainsP Rosel, B Arranz, J Vallejo, et al.
Pageof 4